ProMeta ist unsere Plattform für Gremienarbeit und Projektmanagement.
Prometa login
From natural substances and phytoextracts to the development of new active ingredients, from product design, formulation and quality management to drug delivery and new materials for medical technology
Download Programme Enzymes are considered to be little miracle substances for innovation, process advantages and cost reductions. Whether in the food...
Advances in isolation, handling and analytics of single cells
Thank you for your participation in the FOA 2016 Group Foto for Download here International Adsorption...
PRAXISforum Future Production 2019 In the last years chemical and pharmaceutical industry companies are working on two major production concepts to...
Get updated about 3D cell cultures as predictive, physiological relevant model systems! These questions will be addressed – and answered – at 3DCC 2016:...
These recommendations of Working Group Upstream Processing of the DECHEMA expert group “Single-use technology in biopharmaceutical manufacturing” aim to select suitable experimental methods for the characterisation of single-use bioreactors (SUB) and mixers (SUM). The described methods are applicable to a broad range of of single-use systems and applications. The guidelines can also be used for the engineering characterisation of reusable systems. Furthermore, these process engineering characterisation methods intend to offer manufacturers and operators of SUB and SUM a uniform set of methods and instruments through validated Standard Operating Procedures (SOPs).
The online Registration is already closed Please register on-site (Only with Creditcard We are lookin...
Production, analytics & regulatory aspects of advanced therapy medicinal products
The Subject Division Plant based Extracts - Products and Processes of ProcessNet (an initiative of DECHEMA – Society for Chemical Engineering and...
New production systems and innovative manufacturing methods such as single-use technologies bring about new challenges for quality control of biopharmaceutical production processes. In its most recent publication, the DECHEMA Working Group “Single-use technology in biopharmaceutical manufacturing” gives recommendations for a risk analysis of these processes. Based on prior publications, the compact paper lists the regulatory background as well as potential risks related to material, processes, or products. An example of an industrial application shows how risk values can be defined and risk levels calculated in order to determine appropriate countermeasures. This recommendation is based on an article in Adv. Biochem. Eng. Biotechnol. The original publication is available at www.springerlink.com.
